Delivery Order SPE2DB22D2006-SPE2DB24FV8ZM

Award Date 3/21/24
Potential Completion Date 3/22/24
Potential Value $9.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is a delivery order valued at $1,496.44 for the supply of the antiretroviral medication BIKTARVY. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, with a performance period through March 11, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $22,982.83 delivery order covers the supply of Biktarvy 50-200-25 30S, a prescription medication, to support military healthcare programs. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award, valued at $18,060.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $19,671.99 firm fixed price contract is for the delivery of the HIV medication BIKTARVY 50-200-25 MG TABLET in 30-count packages. This award is a part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $80,169.87 firm fixed price delivery order is for the supply of Biktarvy 50-200-25 mg tablets, a brand name antiretroviral medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary contract vehicle...
This federal contract award is a delivery order issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical sourcing and distribution company. The $14,321.64 fixed-price contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a brand name antiretroviral medication. The contract has a performance period through March 13, 2024 and is not associated with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,035.68 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a medication used to treat HIV infection. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,326.01 delivery order contract, awarded by the Defense Logistics Agency (DLA), is for the supply of the HIV medication BIKTARVY 50-200-25 MG TABLET. The contract has a firm fixed price and runs through February 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $7,175.27, is for the delivery of the HIV treatment medication Biktarvy. The contract is a Firm Fixed Price Delivery Order and does not have any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a contract award to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $37,411 firm-fixed-price delivery order is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FV8ZM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $9,392.12 firm fixed price delivery order is for the supply of Biktarvy, a brand name antiretroviral medication, to support military treatment programs and facilities.

Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense through December 2025. This IDC was awarded solely to Amerisourcebergen Drug Corp without any set-aside designations. In addition, the company holds a separate $750,000 indefinite delivery contract with the Department of Justice Federal Bureau of Investigation to provide medical supplies and medications through May 2024.

Generated 6/20/24, 9:39 AM